iShares Biotechnology ETF $IBB Stock Position Decreased by Realta Investment Advisors

Realta Investment Advisors decreased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 89.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 456 shares of the financial services provider’s stock after selling 3,941 shares during the quarter. Realta Investment Advisors’ holdings in iShares Biotechnology ETF were worth $77,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the business. Allspring Global Investments Holdings LLC lifted its stake in iShares Biotechnology ETF by 46,806.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after buying an additional 46,806 shares during the last quarter. Tudor Investment Corp ET AL bought a new position in shares of iShares Biotechnology ETF during the third quarter worth about $931,000. WorthPointe LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter worth about $1,424,000. Central Pacific Bank Trust Division grew its position in shares of iShares Biotechnology ETF by 296,500.0% during the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after acquiring an additional 14,825 shares during the last quarter. Finally, McElhenny Sheffield Capital Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter worth about $25,400,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.0%

Shares of NASDAQ:IBB opened at $187.38 on Monday. The company’s 50-day moving average price is $171.45 and its 200 day moving average price is $171.04. iShares Biotechnology ETF has a fifty-two week low of $125.70 and a fifty-two week high of $188.69.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.